Table 1 Patient demographic and treatment characteristics
From: High preoperative serum sVCAM-1 concentration as a predictor of early ovarian cancer recurrence
|
Group A n |
Group B n |
All patients n | |
|---|---|---|---|
| Number of patients | 20 | 17 | 37 |
| Age | 63.3±10.8 | 53.9±10.6 | 59 ± 11,6 |
| FIGO stage III | 13 | 15 | 28 |
| FIGO stage IV | 7 | 2 | 9 |
| Serouse tip | 19 | 13 | 32 |
| Endometrioid type | 1 | 4 | 5 |
| G1 | 2 | 3 | 5 |
| G2 | 6 | 5 | 11 |
| G3 | 12 | 9 | 21 |
| Primary citoreductive operation | 6 | 12 | 18 |
| Neoadjuvant chemotherapy | 14 | 5 | 19 |